Insiders · Profile

Ellis Christopher

Chief Operating Officer at Barinthus Biotherapeutics. Filing since 4 May 2021. CIK 0001851664

Company
Date
Role
Action
Shares
Amount
Of holding
25 Aug 2022
Chief Operating Officer
Sold, plan not stated
39,176
$257.40K
99.8%
24 Aug 2022
Chief Operating Officer
Sold, plan not stated
450
$2.15K
85.7%
18 Aug 2022
Chief Operating Officer
Sold, plan not stated
2,175
$10.53K
96.7%
17 Aug 2022
Chief Operating Officer
Sold, plan not stated
649
$3.09K
89.6%
16 Aug 2022
Chief Operating Officer
Sold, plan not stated
2,200
$10.51K
96.7%
15 Aug 2022
Chief Operating Officer
Sold, plan not stated
5,350
$25.46K
98.6%
28 Jun 2022
Chief Operating Officer
Sold, plan not stated
5
$30.00
6.3%
4 May 2021
Chief Operating Officer
Bought
75
$1.28K
opened
8 decisions on file.